- STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
- STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital
- STERIS Announces Financial Results for Fiscal 2024 Third Quarter
- STERIS Announces Dividend of $0.52 per share
- STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024
- STERIS Announces Financial Results for Fiscal 2024 Second Quarter
- STERIS to Host a Conference Call for Fiscal 2024 Second Quarter Financial Results on November 8, 2023
- STERIS to Present at the Morgan Stanley Healthcare Conference
- STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD
- STERIS Announces Financial Results for Fiscal 2024 First Quarter
More ▼
Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 125.53 |
Average volume | -- |
---|---|
Shares outstanding | 98.81m |
Free float | 98.54m |
P/E (TTM) | 35.95 |
Market cap | 20.15bn USD |
EPS (TTM) | 5.67 USD |
Annual div (ADY) | 1.92 EUR |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Feb 22 2024 |
Div pay-date | Mar 22 2024 |
Data delayed at least 20 minutes, as of Dec 30 1899.
More ▼